Ajax-Loading

Astellas Pharma Inc. - Interest Income

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Interest-Income" stands at 4.12 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2024, the lowest value since 09/30/2020.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -41.54 percent compared to the value the year prior.
The 1 year change in percent is -41.54.
The 3 year change in percent is -44.35.
The 5 year change in percent is -29.29.

The Serie's long term average value is 6.83 Billion Japanese Yens. It's latest available value, on 12/31/2024, is 39.60 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2019, to it's latest available value, on 12/31/2024, is +105.99%.
The Serie's change in percent from it's maximum value, on 06/30/2021, to it's latest available value, on 12/31/2024, is -67.49%.

Interest Income for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Interest Income905,699,262,464.00
LogoJohnson & Johnson - Interest Income486,508,953,600.00
LogoAbbVie Inc - Interest Income399,570,305,024.00
LogoRoche Holding AG - Interest Income317,433,206,677.55
LogoAstraZeneca PLC - Interest Income280,205,508,085.11